⌘K
Loading ticker…
Fennec Pharmaceuticals Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Fennec Pharmaceuticals Inc. Common Stock (FENC) has a 3-month relative strength percentile of 93 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 65. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.7%, relative volume 3.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 93, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
FENC is held by 3 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $5M notional. Top 3 carry $10M.
Top 3 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $5M |
| IWMiShares Russell 2000 ETF | 0.01% | $4M |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $314K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FENC Jan avg: -1.32% median: 0.71% win: 50% σ: 6.87% n: 4 2022-04-12 → 2026-05-29 | FENC Feb avg: 1.14% median: 1.40% win: 50% σ: 10.46% n: 4 2022-04-12 → 2026-05-29 | FENC Mar avg: -7.74% median: -10.40% win: 25% σ: 18.77% n: 4 2022-04-12 → 2026-05-29 | FENC Apr avg: -3.58% median: -1.56% win: 20% σ: 8.47% n: 5 2022-04-12 → 2026-05-29 | FENC May avg: 10.54% median: -1.13% win: 40% σ: 32.32% n: 5 2022-04-12 → 2026-05-29 | FENC Jun avg: 1.64% median: -0.03% win: 50% σ: 11.09% n: 4 2022-04-12 → 2026-05-29 (current) | FENC Jul avg: 6.27% median: 3.40% win: 75% σ: 9.47% n: 4 2022-04-12 → 2026-05-29 | FENC Aug avg: -2.28% median: -1.81% win: 50% σ: 10.61% n: 4 2022-04-12 → 2026-05-29 | FENC Sep avg: 0.76% median: -1.22% win: 50% σ: 12.16% n: 4 2022-04-12 → 2026-05-29 | FENC Oct avg: -6.24% median: -10.39% win: 25% σ: 10.12% n: 4 2022-04-12 → 2026-05-29 | FENC Nov avg: 18.69% median: 17.95% win: 75% σ: 16.99% n: 4 2022-04-12 → 2026-05-29 | FENC Dec avg: 6.78% median: 1.33% win: 50% σ: 16.34% n: 4 2022-04-12 → 2026-05-29 |